Estimation of the Long Term Effectiveness of Routine Use of Cardiac Shock Wave Therapy

• Status: Withdrawn
• Trial end date: 2021-09-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is dedicated to determination of the long term effectiveness of coronary heart disease (CHD) treatments - cardiac shock wave therapy (CSWT) in comparison with other kinds of medical and surgical treatment. For that purpose the investigators will observe the patients with CHD who enrolled in this study in their routine course of treatment. But the investigators will not interfere with the patient treatment. Each participant will be followed-up for five years. The collected data will allow to determine if the particular method, CSWT, could really make any additional contribution to the more traditional methods of CHD treatment and if the CSWT is only temporarily effective or could exert the long term effect as well.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: City Hospital No 40, Saint Petersburg, Russia
• Treatments: Amlodipine; Aspirin; Atenolol; Enalapril; Enalaprilat; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isosorbide; Isosorbide Dinitrate; Isosorbide-5-mononitrate; Nitroglycerin

Criteria

Inclusion Criteria:

1. Age 18 years and older.

2. Diagnosed or suspected CHD.

3. Willingness to participate in the study.

Exclusion Criteria:

• Inability of a patient to make an independent decision on participation in the study because of intellectual decline (article 29 of Helsinki Declaration)